Wow, the REVERSE Trial studying the benefits of cardiac resynchronization therapy on asymptomatic (New York Heart Association Class I) to minimally-symptomatic (NYHA Class II) are set to be presented at 10:30 today here in Chicago at the ACC Meeting, but this press release of the results is available at 09:00 CST on-line.
This pre-release reporting continues to undermine any reason doctors might want to attend these meetings any longer - it's more efficient to sit at work and surf the 'net.
-Wes
No comments:
Post a Comment